Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000203350

Medchemexpress LLC Mc-Val-Cit-PAB-Gefitinib (chloride) | 98.7% | 1038.00 g·mol-1 | C50H63Cl2FN10O9 | 1 MG
SDP

Catalog No. 5000203350
Encompass_Preferred

Mc-Val-Cit-PAB-Gefitinib (chloride) is a drug-linker conjugate consisting of the EGFR inhibitor gefitinib coupled to an Mc-Val-Cit-PAB linker, supplied for research use only.

  • Drug-linker conjugate of gefitinib and Mc-Val-Cit-PAB linker.
  • White to off-white solid appearance.
  • Molecular formula C50H63Cl2FN10O9.
  • Molecular weight 1038.00 g·mol-1.
  • Reported purity 98.7%.
  • Intended for research use only; not for human or animal therapeutic use.
  • Store at -20°C in a sealed container, away from moisture and light.
  • Available in small milligram package sizes for laboratory research.

Catalog No. 50-002-03350 Supplier Medchemexpress LLC Supplier No. HY1488711MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Mc-Val-Cit-PAB-Gefitinib (chloride) is a drug-linker conjugate consisting of the EGFR inhibitor gefitinib coupled to an Mc-Val-Cit-PAB linker, supplied for research use only.

  • Drug-linker conjugate of gefitinib and Mc-Val-Cit-PAB linker.
  • White to off-white solid appearance.
  • Molecular formula C50H63Cl2FN10O9.
  • Molecular weight 1038.00 g·mol-1.
  • Reported purity 98.7%.
  • Intended for research use only; not for human or animal therapeutic use.
  • Store at -20°C in a sealed container, away from moisture and light.
  • Available in small milligram package sizes for laboratory research.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.